What Is 2-Oxo-4-methylvaleric acid

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 2-Oxo-4-methylvaleric acid is an organic compound with the molecular formula C6H10O3, commonly associated with metabolic disorders such as maple syrup urine disease (MSUD). It is a keto acid derivative of the branched-chain amino acid leucine. Elevated levels in blood or urine serve as a clinical marker for MSUD, a rare inherited disorder affecting approximately 1 in 185,000 newborns globally.

Key Facts

2-Oxo-4-methylvaleric acid has the molecular formula C6H10O3 and a molecular weight of 130.14 g/mol
It is a metabolic byproduct of leucine catabolism and accumulates in maple syrup urine disease (MSUD)
MSUD affects about 1 in 185,000 infants worldwide, with higher incidence in certain populations
The compound is structurally similar to alpha-keto acids and contains a branched methyl group at carbon 4
Diagnosis of MSUD often involves detecting elevated levels of 2-oxo-4-methylvaleric acid via tandem mass spectrometry

Overview

2-Oxo-4-methylvaleric acid is a key intermediate in the catabolic pathway of the essential amino acid leucine. It arises when the enzyme branched-chain alpha-keto acid dehydrogenase complex (BCKAD) fails to process its substrate, leading to toxic accumulation in metabolic disorders. This compound is particularly significant in diagnosing and understanding inborn errors of metabolism.

Its presence in abnormal concentrations in blood or urine signals a disruption in normal metabolic function, especially in patients with maple syrup urine disease (MSUD). The compound’s chemical structure includes a ketone functional group and a branched alkyl chain, contributing to its detection via mass spectrometry. Because of its clinical relevance, it is routinely screened in newborns in many countries.

Chemical formula: The compound has the molecular formula C6H10O3, with a molar mass of 130.14 g/mol, making it identifiable through precise mass analysis.
Structure: It features a five-carbon backbone with a methyl group on the fourth carbon and a ketone group on the second carbon, classifying it as an alpha-keto acid.
Metabolic origin: Formed during the transamination of leucine, a branched-chain amino acid, primarily in the liver and muscle tissues.
Detection method: Identified using tandem mass spectrometry (MS/MS), a standard technique in newborn screening panels for metabolic disorders.
Pathological significance: Elevated levels are strongly correlated with maple syrup urine disease, a rare autosomal recessive disorder affecting amino acid metabolism.

How It Works

2-Oxo-4-methylvaleric acid functions as a metabolic intermediate that reveals disruptions in the breakdown of leucine. Under normal conditions, it is rapidly decarboxylated by the BCKAD complex, but in MSUD, enzyme deficiency causes buildup.

Enzyme deficiency: In MSUD, mutations in the BCKDHA, BCKDHB, or DBT genes impair the BCKAD complex, preventing normal metabolism of the compound.
Toxic accumulation: High concentrations of 2-oxo-4-methylvaleric acid in the blood lead to neurological damage, vomiting, lethargy, and seizures in infants.
Diagnostic marker: Its detection in plasma or urine at levels exceeding 100 µmol/L is a hallmark of acute MSUD episodes.
Leucine connection: The acid is the alpha-keto analog of leucine, formed via transamination by branched-chain aminotransferase (BCAT).
Metabolic pathway: Normally, it proceeds to oxidative decarboxylation, but in MSUD, it accumulates and is excreted in urine with a characteristic sweet odor.
Therapeutic monitoring: Levels are tracked during dietary management to ensure leucine-restricted diets are effectively reducing toxic metabolite production.

Comparison at a Glance

The following table compares 2-oxo-4-methylvaleric acid with related metabolites in amino acid catabolism:

Compound	Parent Amino Acid	Molecular Formula	Associated Disorder	Normal Plasma Level
2-Oxo-4-methylvaleric acid	Leucine	C6H10O3	Maple Syrup Urine Disease	<10 µmol/L
2-Oxoisovaleric acid	Valine	C5H8O3	MSUD (variant forms)	<5 µmol/L
Phenylpyruvic acid	Phenylalanine	C9H8O3	Phenylketonuria	Undetectable
3-Methyl-2-oxovaleric acid	Isoleucine	C6H10O3	MSUD	<8 µmol/L
Alpha-ketoglutaric acid	Glutamate	C5H6O5	None (normal metabolite)	20–50 µmol/L

This comparison highlights how 2-oxo-4-methylvaleric acid is uniquely tied to leucine metabolism and MSUD. Unlike general keto acids such as alpha-ketoglutarate, its elevation is pathological. Monitoring these compounds allows clinicians to differentiate between inborn errors and tailor treatments accordingly, especially in neonatal care.

Why It Matters

Understanding 2-oxo-4-methylvaleric acid is crucial for early diagnosis and management of life-threatening metabolic conditions. Its detection can prevent irreversible brain damage through timely dietary and medical intervention.

Newborn screening: Over 90% of U.S. states include MSUD in newborn screening panels, relying on detection of this acid via MS/MS.
Preventive care: Early identification allows for immediate implementation of a low-leucine diet, preventing metabolic crises.
Genetic counseling: Families with a history of MSUD can undergo prenatal testing to assess fetal risk based on metabolite levels.
Therapeutic targets: Research into enzyme replacement and gene therapy focuses on restoring BCKAD function to normalize acid levels.
Public health impact: MSUD screening has reduced mortality from over 50% in untreated cases to less than 10% with early treatment.
Diagnostic accuracy: Measuring 2-oxo-4-methylvaleric acid improves specificity, reducing false positives compared to leucine-only screening.

As metabolic medicine advances, the role of precise biomarkers like 2-oxo-4-methylvaleric acid continues to grow. Its detection exemplifies how biochemical insights translate into life-saving clinical practices, especially in pediatric genetics and nutrition.